Be a Smart Investor
Monday, April 24, 2017
D-Day For CAPR Today, OMED Hands Out Pink Slips, JAZZ Hits Right Notes...
Capricor Therapeutics will be announcing 6-month results from its phase I/II DMD trial of CAP-1002 today.
from RTT - Biotech http://ift.tt/2oFjjPA
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment